Cyclacel Pharmaceuticals Inc

Cyclacel Pharmaceuticals Inc

CYCC

Get informed when a big investor buys or sells

+ Follow
Market Cap$11.31M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cyclacel Pharmaceuticals IncCyclacel Pharmaceuticals Inc-1.9--24%--
$0.39

Current Fair Value

93.9% downside

Overvalued by 93.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$11.31 Million
Enterprise Value$7.97 Million
Dividend Yield$0.15 (-)
Earnings per Share$-6.45
Beta0.16
Outstanding Shares5,458,564

Return

Return on Equity-23.68%ROE
Return on Assets-21.16%
Return on Invested Capital-124.52%

Valuation & Multiples

P/E Ratio-1.93P/E Ratio
PEG-1.35PEG
Price to Sales-Price to Sales
Price to Book Ratio6.37Price to Book Ratio
Enterprise Value to Revenue10.66
Enterprise Value to EBIT-0.95
Enterprise Value to Net Income-5
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
November 13, 2025
EPS Estimate
$-72.00
Average shareholder expectation
Revenue Estimate
$25,000
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.62% 3.56%
Total Invested$116,974 2018.33%
Investors Holding9 3.00%

ESG Score

No data

About Bio Green Med Solution, Inc.

2,018 employees
CEO: Sing Ee Wong

A diversified company operating in both the fire protection and biopharmaceutical industries. It expanded its portfolio by acquiring Fitters Sdn. Bhd., a Malaysian fire protection products and services group. Focuses on advancing opportu...